CYP1A1 and breast carcinoma: Consistent with these findings, earlier studies documented preferential repression of Cyp1a1 in DMBA-induced mammary tumors [48], as well as in human invasive ductal carcinomas [61, 62] and breast cancer cells lacking the ERα [50, 63].